圣诺生物(688117.SH):子公司签订不超3.5亿元GLP-1多肽原料药销售合同

智通财经网
17 Sep 2024

智通财经APP讯,圣诺生物(688117.SH)公告,公司全资子公司成都圣诺生物制药有限公司(“圣诺制药”)于近日与某客户签订了《产品采购合同》,向合同对方供应GLP-1多肽原料药,合同金额为不超过人民币3.5亿元(含税)。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10